These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 33656625

  • 1. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
    Bigham M, Mohammadipour A, Hosseini M, Malvandi AM, Ebrahimzadeh-Bideskan A.
    Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
    [Abstract] [Full Text] [Related]

  • 2. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S, Bashiri K, Kiasalari Z, Baluchnejadmojarad T, Sedaghat R, Roghani M.
    Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
    [Abstract] [Full Text] [Related]

  • 3. [The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease].
    Xu L, Liu LX, Chen WF, Xie JX, Huang WX.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):1-5. PubMed ID: 21141541
    [Abstract] [Full Text] [Related]

  • 4. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.
    Jamali-Raeufy N, Mojarrab Z, Baluchnejadmojarad T, Roghani M, Fahanik-Babaei J, Goudarzi M.
    Metab Brain Dis; 2020 Mar; 35(3):539-548. PubMed ID: 32016817
    [Abstract] [Full Text] [Related]

  • 5. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H, Jia L, Chen X, Shi L, Xie J.
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [Abstract] [Full Text] [Related]

  • 6. Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease.
    Chen HH, Chang PC, Chen C, Chan MH.
    Pharmacol Rep; 2018 Aug; 70(4):668-676. PubMed ID: 29909247
    [Abstract] [Full Text] [Related]

  • 7. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H.
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [Abstract] [Full Text] [Related]

  • 8. Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.
    Güzelad Ö, Özkan A, Parlak H, Sinen O, Afşar E, Öğüt E, Yıldırım FB, Bülbül M, Ağar A, Aslan M.
    Metab Brain Dis; 2021 Jun; 36(5):1003-1014. PubMed ID: 33666819
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 10. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH, Fabricius K, Barkholt P, Mikkelsen JD, Jelsing J, Pyke C, Knudsen LB, Vrang N.
    Brain Res; 2016 Sep 01; 1646():354-365. PubMed ID: 27233809
    [Abstract] [Full Text] [Related]

  • 11. Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.
    Thornton E, Vink R.
    PLoS One; 2012 Sep 01; 7(4):e34138. PubMed ID: 22485158
    [Abstract] [Full Text] [Related]

  • 12. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
    Meng JL, Ma YY, Luo HY, Kong SZ, He YW, Dong BC, Wu SH, He M.
    Sheng Li Xue Bao; 2008 Jun 25; 60(3):369-74. PubMed ID: 18560728
    [Abstract] [Full Text] [Related]

  • 13. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Sleeman IJ, Boshoff EL, Duty S.
    Neuropharmacology; 2012 Dec 25; 63(7):1268-77. PubMed ID: 22971544
    [Abstract] [Full Text] [Related]

  • 14. Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease.
    Farzam SA, Darabi S, Haghdoost-Yazdi H, Zaferani Y.
    Neurol Res; 2024 Aug 25; 46(8):763-771. PubMed ID: 38740025
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B, Xu D, Duan H, Du J, Zhang Z, Lee SM, Wang Y.
    Biol Pharm Bull; 2014 Aug 25; 37(2):274-85. PubMed ID: 24305623
    [Abstract] [Full Text] [Related]

  • 16. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
    Antunes MS, Ladd FVL, Ladd AABL, Moreira AL, Boeira SP, Cattelan Souza L.
    Metab Brain Dis; 2021 Jan 25; 36(1):153-167. PubMed ID: 33057922
    [Abstract] [Full Text] [Related]

  • 17. Ineffectiveness of saxagliptin as a neuroprotective drug in 6-OHDA-lesioned rats.
    Turnes JM, Bassani TB, Souza LC, Vital MABF.
    J Pharm Pharmacol; 2018 Aug 25; 70(8):1059-1068. PubMed ID: 29766510
    [Abstract] [Full Text] [Related]

  • 18. Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model.
    Ozsoy O, Yildirim FB, Ogut E, Kaya Y, Tanriover G, Parlak H, Agar A, Aslan M.
    Free Radic Res; 2015 Aug 25; 49(8):1004-14. PubMed ID: 25791066
    [Abstract] [Full Text] [Related]

  • 19. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease.
    Khan MM, Raza SS, Javed H, Ahmad A, Khan A, Islam F, Safhi MM, Islam F.
    Neurotox Res; 2012 Jul 25; 22(1):1-15. PubMed ID: 22194158
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X, Hariri DJ, Caballero B, Zhang S, Bartlett MJ, Kaut O, Mount DW, Wüllner U, Sherman SJ, Falk T.
    Neuroscience; 2014 Jan 31; 258():385-400. PubMed ID: 24291725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.